全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
-  2019 

分化差的胃神经内分泌肿瘤预后分析

DOI: 10.3971/j.issn.1000-8578.2019.18.1770

Keywords: A Meta-analysis,Value of 18F-FDG PET/CT in Evaluating Chemotherapeutic Effect of Diffuse Large B Cell Lymphoma Patients with Different CD5 Expression,Advances in Prognostic Value of Peripheral Blood Inflammatory Indexes in Non-small Cell Lung Cancer,Efficacy and Prognostic Factors of Docetaxel Rechallenge on Metastatic Castrationresistant Prostate Cancer Patients,Comparison of Survival and Postoperative Complication of Stage Ⅰb2-Ⅱa2 Cervical Cancer Patients Among Three Kinds of Therapeutic Regimens,Cholesterol: A Predictor of Risk and Prognosis of Breast Cancer,Predictive Value of Preoperative Hematologic Inflammatory Markers in Prognostic of Glioma Patients,Clinical Treatment and Prognosis of 101 Patients with Small Cell Neuroendocrine Carcinoma of Cervix,Effect of Marital Status on Survival of Lung Cancer Patients Investigated Based on SEER Database,Clinical Characteristics and Prognosis of Primary Thyroid Lymphoma Patients,Prognostic Factors and Comprehensive Treatment of 95 Synovial Sarcoma Patients

Full-Text   Cite this paper   Add to My Lib

Abstract:

摘要 目的 探讨分化差的胃神经内分泌肿瘤的临床病理特点和辅助治疗对预后的影响。方法 回顾性分析经根治性手术治疗的胃神经内分泌肿瘤124例,根据肿瘤分类标准对肿瘤进行分类、分级和分期,并进行随访,采用Kaplan-Meier法绘制生存曲线,Log rank检验进行单因素分析,Cox比例风险回归模型进行多因素分析。结果 胃神经内分泌瘤、胃神经内分泌癌和混合性腺神经内分泌癌的5年生存率分别为100%、52.4%和38.8%,多因素分析示淋巴结转移与否(P=0.030)和有无辅助治疗(P=0.017),尤其是顺铂联合依托泊苷方案(HR=0.051, P=0.015)是影响胃神经内分泌癌患者的独立预后因素;而淋巴结转移、远处转移、TNM分期和有无辅助治疗均不是混合性腺神经内分泌癌患者的独立预后因素。结论 胃神经内分泌癌患者的预后与淋巴结转移和有无辅助治疗有关,其辅助治疗可以考虑顺铂联合依托泊苷方案

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133